Li Lei, Liu Rui, Yu Zhonghua, He Jing, Wei Quan
Department of Rehabilitation Medicine and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
Key Laboratory of Rehabilitation Medicine in Sichuan Province, Chengdu, Sichuan, PR China.
Top Stroke Rehabil. 2025 Jul;32(5):492-501. doi: 10.1080/10749357.2024.2437328. Epub 2024 Dec 9.
This study aimed to evaluate the clinical efficacy and safety of inspiratory and expiratory muscle training (IEMT) for patients who underwent tracheostomy after stroke.
The study was an investigator-initiated, single-center, two-arm, evaluator-blinded, randomized clinical trial conducted at West China Hospital of Sichuan University, China, from January 2022 to June 2022. The patients were randomly divided into the intervention group and control group. Patients in both groups received conventional clinical, rehabilitation treatment and usual care. The intervention group also received IEMT for three weeks. There were three primary outcomes including maximal inspiratory pressure (MIP, cmHO), maximal expiratory pressure (MEP, cmH2O) and decannulation outcome after intervention (n, %). The secondary outcomes were other respiratory function outcomes, motor function, activities of daily living (ADL), quality of life (QoL) and the new pulmonary infection rate after the intervention at three weeks.
A total of 50 participants were enrolled [25 in each group; 39 (78%) were men; mean (SD) age, 55.94 (11.97) years]. At three weeks, significant differences were found in the MIP [control vs IEMT: 39.04 (6.21) vs 56.28 (10.41), < 0.001]; MEP [43.48 (5.36) vs 62.16 (10.18), < 0.001], and tracheal tube extraction success rate [2 (8%) vs 9 (36%), = 0.019] between the two groups. In addition, the new pulmonary infection rate in the intervention groups were significantly different (all < 0.05) from those in the control group.
IEMT can improve respiratory function, decannulation outcome, among patients with tracheostomy after stroke.
本研究旨在评估吸气和呼气肌肉训练(IEMT)对中风后接受气管切开术患者的临床疗效和安全性。
该研究是一项由研究者发起的、单中心、双臂、评估者盲法、随机临床试验,于2022年1月至2022年6月在中国四川大学华西医院进行。患者被随机分为干预组和对照组。两组患者均接受常规临床、康复治疗和常规护理。干预组还接受了为期三周的IEMT。有三个主要结局,包括最大吸气压(MIP,cmH₂O)、最大呼气压(MEP,cmH₂O)和干预后的拔管结局(n,%)。次要结局是其他呼吸功能结局、运动功能、日常生活活动(ADL)、生活质量(QoL)以及干预三周后的新发肺部感染率。
共纳入50名参与者[每组25名;39名(78%)为男性;平均(标准差)年龄为55.94(11.97)岁]。在三周时,两组之间在MIP[对照组与IEMT组:39.04(6.21)对56.28(10.41),P<0.001]、MEP[43.48(5.36)对62.16(10.18),P<0.001]和气管导管拔除成功率[2例(8%)对9例(36%),P = 0.019]方面存在显著差异。此外,干预组的新发肺部感染率与对照组相比有显著差异(均P<0.05)。
IEMT可改善中风后气管切开术患者的呼吸功能和拔管结局。